|
KMID : 1030220200210030120
|
|
Journal of Korean Diabetes
2020 Volume.21 No. 3 p.120 ~ p.125
|
|
|
Management of Diabetes in Coronavirus Disease 2019: Prognosis and Practical Issues
|
|
Kim Hye-Soon
|
|
|
Abstract
|
|
|
|
The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a global pandemic by the World Health Organization on March 11, 2020. COVID-19 pandemic emphasizes the importance of understanding the pathophysiology which can potentially influence the treatment choices of people with chronic disease such as type 2 diabetes. The reasons for worse prognosis with COVID-19 in people with diabetes include age, sex, ethnicity, comorbidities such as hypertension, cardiovascular disease, obesity and a proinflammatory status. Medications for glucose-lowering and antihypertensive agents should be carefully assessed which can modulate the risk or may have potential interactions with SARS-CoV-2. It is also important to note that SARS-CoV-2 may exacerbate glucose metabolism through direct beta-cell damage, leading to acute hyperglycemic complications and potential new onset diabetes.
|
|
|
KEYWORD
|
|
|
Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Type 2 diabetes
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|